31.9 C
New York
August 8, 2022
Business Coronavirus Health news Pharmaceuticals industry Vaccines and immunisation World news

Moderna says booster produces strong antibody response to Omicron

Pharmaceuticals firm says third dose of its Covid vaccine increases antibodies against variant by 37-fold

The pharmaceuticals company Moderna has said a booster dose of its Covid vaccine appeared to protect against the fast-spreading Omicron variant in laboratory testing and that the current version will continue to be its “first line of defence against Omicron”.

The decision to focus on the current vaccine, mRNA-1273, was driven in part by how quickly the variant is spreading. The company plans to develop a vaccine specifically to protect against Omicron, which it hopes to advance into clinical trials early next year.

Continue reading…

Related posts

Neglect Africa now and we will face labour shortages globally, IMF warns


‘A bloodbath’: refugees reel from deadly Melilla mass crossing


Taiwan won’t go into lockdown like Shanghai despite Covid surge, premier says